- Home
- CODX vs TLPH Comparison
CODX vs TLPH Comparison
Compare CODX & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- TLPH
- Stock Information
- Founded
- CODX 2013
- TLPH 2005
- Country
- CODX United States
- TLPH United States
- Employees
- CODX N/A
- TLPH N/A
- Industry
- CODX Medical/Dental Instruments
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- CODX Health Care
- TLPH Health Care
- Exchange
- CODX Nasdaq
- TLPH Nasdaq
- Market Cap
- CODX 9.8M
- TLPH 10.6M
- IPO Year
- CODX 2017
- TLPH 2011
- Fundamental
- Price
- CODX $0.28
- TLPH $0.44
- Analyst Decision
- CODX Buy
- TLPH Strong Buy
- Analyst Count
- CODX 2
- TLPH 1
- Target Price
- CODX $5.50
- TLPH $6.00
- AVG Volume (30 Days)
- CODX 462.7K
- TLPH 43.2K
- Earning Date
- CODX 08-07-2025
- TLPH 08-13-2025
- Dividend Yield
- CODX N/A
- TLPH N/A
- EPS Growth
- CODX N/A
- TLPH N/A
- EPS
- CODX N/A
- TLPH N/A
- Revenue
- CODX $3,497,583.00
- TLPH $27,000.00
- Revenue This Year
- CODX N/A
- TLPH N/A
- Revenue Next Year
- CODX $42.11
- TLPH $14,533.26
- P/E Ratio
- CODX N/A
- TLPH N/A
- Revenue Growth
- CODX N/A
- TLPH N/A
- 52 Week Low
- CODX $0.23
- TLPH $0.43
- 52 Week High
- CODX $2.23
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- CODX 43.19
- TLPH 35.99
- Support Level
- CODX $0.26
- TLPH $0.45
- Resistance Level
- CODX $0.29
- TLPH $0.52
- Average True Range (ATR)
- CODX 0.02
- TLPH 0.03
- MACD
- CODX 0.00
- TLPH -0.01
- Stochastic Oscillator
- CODX 26.83
- TLPH 11.11
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.